Literature DB >> 16309234

Endothelial cell survivin is involved in the growth of ovarian endometriotic cysts.

Gaia Goteri1, Guendalina Lucarini, Tiziana Pieramici, Alessandra Filosa, Armanda Pugnaloni, Nina Montik, Graziella Biagini, Andrea Luigi Tranquilli, Guidalberto Fabris, Andrea Ciavattini, Lorenzo Lo Muzio.   

Abstract

BACKGROUND: The aim of the present study was to evaluate microvessel density (MVD) in the cellular layers of ovarian endometriomata, with particular interest in the relationship with VEGF and survivin expressions by endothelial cells and with the diameter of the cysts.
MATERIALS AND METHODS: MVD and VEGF and survivin endothelial cell expressions were evaluated in 26 ovarian endometriotic cysts and correlated with the cyst diameter.
RESULTS: The mean MVD was higher in the inner specialized stroma of ectopic endometrium than in the outer fibrous capsule, but only in the fibrous capsule was MVD correlated with endothelial cell VEGF and survivin expressions as well as with the cyst diameter.
CONCLUSION: The diameter of ovarian endometriotic cysts seems to be related to the angiogenic process involving the outer fibrous capsule, and not the inner specialized stroma of ectopic endometrium, since only in the capsule are vessels stimulated to proliferate by VEGF and protected from apoptosis by survivin, and their density is correlated to cyst diameter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309234

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect.

Authors:  A A V Paupoo; Z B Zhu; M Wang; D T Rein; A Starzinski-Powitz; D T Curiel
Journal:  Hum Reprod       Date:  2010-06-23       Impact factor: 6.918

Review 2.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Proangiogenetic molecules, hypoxia-inducible factor-1alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts.

Authors:  Gaia Goteri; Guendalina Lucarini; Antonio Zizzi; Corrado Rubini; Roberto Di Primio; Andrea Luigi Tranquilli; Andrea Ciavattini
Journal:  Virchows Arch       Date:  2010-05-16       Impact factor: 4.064

4.  Sex hormone regulation of survivin gene expression.

Authors:  Nancy H Nabilsi; Russell R Broaddus; Adrienne S McCampbell; Karen H Lu; Henry T Lynch; Lee-May Chen; David S Loose
Journal:  J Endocrinol       Date:  2010-08-26       Impact factor: 4.286

5.  Hyperglycemia attenuates angiogenic capability of survivin in endothelial cells.

Authors:  Qinhui Song; Xiaojin An; Dongmei Li; Neel R Sodha; Munir Boodhwani; Ye Tian; Frank W Sellke; Jian Li
Journal:  Microvasc Res       Date:  2009-08-27       Impact factor: 3.514

6.  Uncoupling of Vascular Endothelial Growth Factor (VEGF) and Inducible Nitric Oxide Synthase (iNOS) in Gingival Tissue of Type 2 Diabetic Patients.

Authors:  Guendalina Lucarini; Giacomo Tirabassi; Antonio Zizzi; Giancarlo Balercia; Alexia Quaranta; Corrado Rubini; Simone Domenico Aspriello
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

7.  Oxidation-sensitive nociception involved in endometriosis-associated pain.

Authors:  Kristeena Ray; Johannes Fahrmann; Brenda Mitchell; Dennis Paul; Holly King; Courtney Crain; Carla Cook; Mikhail Golovko; Stephen Brose; Svetlana Golovko; Nalini Santanam
Journal:  Pain       Date:  2015-03       Impact factor: 7.926

8.  Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis.

Authors:  Milena Acimovic; Snezana Vidakovic; Natasa Milic; Katarina Jeremic; Milos Markovic; Ana Milosevic-Djeric; Gordana Lazovic-Radonjic
Journal:  J Med Biochem       Date:  2015-12-30       Impact factor: 3.402

Review 9.  The twisted survivin connection to angiogenesis.

Authors:  C Sanhueza; S Wehinger; J Castillo Bennett; M Valenzuela; G I Owen; A F G Quest
Journal:  Mol Cancer       Date:  2015-11-19       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.